Oral contraceptives and venous thromboembolism

This publication has 19 references indexed in Scilit:

• Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
  BMJ, 1996
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
  The Lancet, 1995
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  The Lancet, 1995
• Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
  The Lancet, 1995
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study
  The Lancet, 1995
• Risk Factors for Fatal Venous Thromboembolism in Young Women: A Case-Control Study
  International Journal of Epidemiology, 1992
• Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease
  American Journal of Epidemiology, 1991
• Oral Contraceptive Oestrogen and Progestin Potencies and the Incidence of Deep Venous Thromboembolism
  International Journal of Epidemiology, 1990
• Oral contraceptives and venous thromboembolism: findings in a large prospective study.
  BMJ, 1986
• Investigation of relation between use of oral contraceptives and thromboembolic disease.
  BMJ, 1968